Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,89 USD | +1,01% | -3,99% | -0,71% |
09/04 | ROYALTY PHARMA PLC : Morgan Stanley herhaalt koopadvies | ZM |
05/03 | Transcript : Royalty Pharma plc Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Royalties
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01-01-96 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 01-01-10 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-23 |
James Reddoch
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-07-08 |
Arthur McGivern
CIO | Chief Investment Officer | - | 12-10-22 |
Sara Klymkowsky
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-12 |
Brienne Kugler
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
George Lloyd
CIO | Chief Investment Officer | 64 | 01-01-11 |
Christopher Hite
BRD | Director/Board Member | 57 | 01-03-20 |
George Grofik
IRC | Investor Relations Contact | - | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01-01-96 |
Errol de Souza
BRD | Director/Board Member | 70 | 01-06-20 |
David Hodgson
BRD | Director/Board Member | 67 | 23-06-22 |
Ted Love
BRD | Director/Board Member | 65 | 30-07-20 |
Henry Fernandez
BRD | Director/Board Member | 65 | 30-07-20 |
Gregory Norden
BRD | Director/Board Member | 66 | 11-02-20 |
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01-01-96 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01-06-20 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 16-06-20 |
Christopher Hite
BRD | Director/Board Member | 57 | 01-03-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 50 000 | 0 | 0 | 95,08 % |
Aandeel B | 1 | 150 743 276 | 0 | 0 | |
Aandeel C | 1 | 446 691 515 | 424 704 211 ( 95,08 %) | 0 |
Bedrijfsgegevens
Royalty Pharma Plc
110 East 59th Street 33rd floor
10022, New York
+212 883 0200
http://www.royaltypharma.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Royalty Pharma Holdings Ltd. operates as an investment holding company. The company was founded on February 10, 2020 and is headquartered in Bristol, the United Kingdom. |
Financial Conglomerates
|
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,71% | 12,46 mld. | |
+27,97% | 672 mld. | |
+23,68% | 550 mld. | |
-7,02% | 351 mld. | |
+14,85% | 317 mld. | |
+6,25% | 292 mld. | |
+2,51% | 211 mld. | |
-0,37% | 203 mld. | |
-10,02% | 194 mld. | |
-11,81% | 144 mld. |
- Beurs
- Aandelen
- Koers RPRX
- Onderneming Royalty Pharma plc